novel treatments being explored for patients with hemophilia: highlights from isth 2024
Published 2 months ago • 72 plays • Length 4:43Download video MP4
Download video MP3
Similar videos
-
1:06
isth 2024 highlights: promising upcoming treatments for hemophilia
-
2:22
the need for novel agents to treat patients with mcl who have relapsed after targeted therapy
-
1:59
assessing if a patient with dlbcl is responding to treatment using pet-ct and novel assays
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
1:17
exciting novel treatments being developed for mds
-
2:54
how novel agents & individualized treatment approaches are improving outcomes in patients with aml
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
1:09
the changing role of allosct in dlbcl in the era of novel agents
-
3:09
overcoming challenges with targeted therapies for cll: high-risk mutations and btki resistance
-
1:41
novel therapies for high-risk mds
-
1:42
the future of cll treatment: aiming for long-lasting remission
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
2:48
the promise of pyruvate kinase activators, such as mitapivat, for treating scd and thalassemia
-
2:19
improving global access to novel immunotherapies for patients with r/r dlbcl
-
1:19
what's on the horizon for the treatment of mpns?